Click here to read the articles and download the PDF

Pharmaceutical Commerce - December 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Did Industry Fumble the DSCSA Deadline?

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Why AI Advances in CGT Require Getting Data Right

Articles

The latest news for pharma industry insiders.

Pharma Pulse 4/2/24: Tackling Barriers to Adopting BYOD, Lonely Men with HIV More Likely to Smoke & more

Syneos Health's Kim Plesnarski uncovers the key issues that customers are currently trying to address, including the retail shift from small-molecule products to biologics. 

Tackling Patient-Related Challenges Along the Pharma Supply Chain

Patients should not have to wait to access the medication they need.

Fail-First Policies Are Harming Patients

Cross-sectional study explores the impact of this monumental Supreme Court ruling. 

How Dobbs v Jackson Women’s Health Organization Decision Influenced Self-Management Medication Use

Videos

In this Pharmaceutical Commerce video interview, Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses what innovative digital solutions and disruptive technologies he sees transforming the landscape of biopharma manufacturing in the future.

Digital Solutions & Disruptive Technologies Transforming the Future Landscape of Biopharma Manufacturing

Pharma Pulse 4/1/24: Uncertainties Associated with Accelerated Approval, Understanding DSCSA & more

Qualitative study breaks down challenges and priorities of the Medicare Shared Savings Program, as noted by affordable care organizations.

Challenges Surrounding the Medicare Shared Savings Program

Fighting for patient affordability doesn’t necessarily require a scapegoat.

In Search of the ‘Bad Guy’

Exploring how current and future legislation may impact the role of pharmacy benefit managers (PBMs).


What Will Change in the Pharma  Industry Look Like?

A breakdown of the issues surrounding retail pharmacy—and what can be done to address these difficulties in a timely manner.

Featured Content

Pharmaceutical Commerce - December 2024

Did Industry Fumble the DSCSA Deadline?

Going Inside the Gross-to-Net Bubble and Its Nuances

Why AI Advances in CGT Require Getting Data Right